To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer

​ Conditions: Renal Cell Carcinoma (RCC)

Interventions: Drug: Anti-Human CD70 T-Cell Injection

Sponsors: Hrain Biotechnology Co., Ltd.; RenJi Hospital

Not yet recruiting Conditions: Renal Cell Carcinoma (RCC)
Interventions: Drug: Anti-Human CD70 T-Cell Injection
Sponsors: Hrain Biotechnology Co., Ltd.; RenJi Hospital
Not yet recruiting